Metformin Role in Diabetic Patients with Tuberculosis: a Review
DOI:
https://doi.org/10.30872/j.trop.pharm.chem.v5i3.217Keywords:
metformin, tuberculosis, type-2 diabetes mellitusAbstract
Tuberculosis (TB) epidemic is a global health challenge, and WHO estimated the incidence of the new cases reaching 11.1 million people in 2017. Indonesia is classified as a high TB burden country, with 8% of its population infected by TB and ranks third in the world. Type-2 diabetes mellitus (T2DM) is known comorbidity for TB patients. TB-T2DM patients have a higher chance of morbidity, mortality, relapse, bacterial resistance, treatment failure, and slower sputum conversion than TB patients without T2DM. Recent studies suggest that metformin may have a potential synergistic role for TB-T2DM patients. Metformin has immunomodulator properties that can improve the body's immune response and inflammatory response against TB in individuals with T2-DM.
References
[1] Park SW, Shin JW, Kim JY, Park IW, Choi BW, Choi JC, et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2012;31(7):1305–10.
[2] Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, Duggirala R, Morales-Romero J, López-Alvarenga JC, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis [Internet]. 2017;103:83–91. Available from: http://dx.doi.org/10.1016/j.tube.2017.01.006
[3] Al-Rifai R, Pearson F, Critchley J, Abu-Raddad L. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One. 2017;12(11):e0187967.
[4] Ma Y, Huang ML, Li T, Du J, Shu W, Xie SH, et al. Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China. Biomed Environ Sci [Internet]. 2017;30(9):671–5. Available from: http://dx.doi.org/10.3967/bes2017.089
[5] Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171–85.
[6] Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13–24.
[7] Restrepo BI, Schlesinger LS. Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract [Internet]. 2014 Nov;106(2):191–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf
[8] Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Med. 2008;5(7):1091–101.
[9] Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis [Internet]. 2009;9(12):737–46. Available from: http://dx.doi.org/10.1016/S1473-3099(09)70282-8
[10] Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Med [Internet]. 2011;9(1):81. Available from: http://www.biomedcentral.com/1741-7015/9/81
[11] Vashisht R, Brahmachari SK. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med. 2015;13(1):1–3.
[12] Wu T, Xie C, Wu H, Jones KL, Horowitz M, Rayner CK. Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes. Diabetes, Obes Metab. 2017;19(2):290–3.
[13] Ma Y, Pang Y, Shu W, Liu YH, Ge QP, Du J, et al. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up. Eur J Clin Microbiol Infect Dis. 2018;37(7):1259–63.
[14] Singhal A, Jie L, Kumar P, Hong GS, Leow MKS, Paleja B, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014;6(263).
[15] Wallis RS, Hafner R. Advancing host-directed therapy for tuberculosis. Nat Rev Immunol [Internet]. 2015;15(4):255–63. Available from: http://dx.doi.org/10.1038/nri3813
[16] Novita BD, Ali M, Pranoto A, Soediono EI, Mertaniasih NM. Metformin induced autophagy in diabetes mellitus – Tuberculosis co-infection patients: A case study. Indian J Tuberc [Internet]. 2019;66(1):64–9. Available from: https://doi.org/10.1016/j.ijtb.2018.04.003
[17] Lee YJ, Han SK, Park JH, Lee JK, Kim DK, Chung HS, et al. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus. Korean J Intern Med. 2018;33(5):933–40.
[18] Pan SW, Yen YF, Kou YR, Chuang PH, Su VYF, Feng JY, et al. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment. Chest [Internet]. 2018;153(6):1347–57. Available from: https://doi.org/10.1016/j.chest.2017.11.040
[19] Marupuru S, Senapati P, Pathadka S, Miraj SS, Unnikrishnan MK, Manu MK. Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility. Brazilian J Infect Dis [Internet]. 2017;21(3):312–6. Available from: http://dx.doi.org/10.1016/j.bjid.2017.01.001
